FDA NDC Directory · JSON-LD · Markdown

Inmazeb

NDC 61755-018 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameatoltivimab, maftivimab, and odesivimab-ebgn
Labeler / ManufacturerRegeneron Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA761169
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsATOLTIVIMAB (241.7 mg/14.5mL)
MAFTIVIMAB (241.7 mg/14.5mL)
ODESIVIMAB (241.7 mg/14.5mL)
Marketing started20201014
Package count1

External sources

Source: openFDA. Public-domain (CC0).